The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies

Hematopoietic cell transplantation (HCT) is widely used for acquired and congenital disorders of the hematopoietic system. Number of transplants done in Europe and associated countries continues to rise with 45,418 HCT in 41,100 patients [(17,155 allogeneic (42%) and 23,945 autologous (58%)] reporte...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Bone Marrow Transplant
Autores principales: Passweg, Jakob R., Baldomero, Helen, Basak, Grzegorz W., Chabannon, Christian, Corbacioglu, Selim, Duarte, Rafael, Kuball, Jürgen, Lankester, Arjan, Montoto, Silvia, de Latour, Régis Peffault, Snowden, John A., Styczynski, Jan, Yakoub-Agha, Ibrahim, Arat, Mutlu, Mohty, Mohamad, Kröger, Nicolaus
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6957459/
https://ncbi.nlm.nih.gov/pubmed/30728439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41409-019-0465-9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares